These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Optimization of the immunosuppressive protocol after lung transplantation. Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269 [TBL] [Abstract][Full Text] [Related]
26. A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion. Thervet E; Morelon E; Ducloux D; Bererhi L; Noël LH; Janin A; Bedrossian J; Puget S; Chalopin JM; Mihatsch M; Legendre C; Kreis H Transplant Proc; 2000 Dec; 32(8):2778. PubMed ID: 11134800 [No Abstract] [Full Text] [Related]
27. Clinical study of FK 506 in renal transplant recipients. Youhua Z; Zhinlian M; Liming W Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900 [No Abstract] [Full Text] [Related]
29. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients. Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482 [No Abstract] [Full Text] [Related]
30. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193 [TBL] [Abstract][Full Text] [Related]
31. Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial. Yang HC; Holman MJ; Langhoff E; Ulsh PJ; Dellock CA; Gupta M; Ahsan N Transplant Proc; 1999; 31(1-2):1121-4. PubMed ID: 10083501 [No Abstract] [Full Text] [Related]
32. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation. Kim HC; Park SB; Kim HT; Cho WH; Park CH Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919 [No Abstract] [Full Text] [Related]
33. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. Lipson DA; Palevsky HI; Kotloff RM; Edelman J Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612 [No Abstract] [Full Text] [Related]
34. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415 [TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients. Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567 [No Abstract] [Full Text] [Related]
36. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group. Carl S; Wiesel M Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619 [No Abstract] [Full Text] [Related]
37. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439 [No Abstract] [Full Text] [Related]
38. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience. Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566 [No Abstract] [Full Text] [Related]
39. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
40. Tolerance of mycophenolate mofetil is dependent on kidney function. Puggia R; Rizzolo M; Maresca MC; Calconi G; Vianello A Transplant Proc; 1998 Aug; 30(5):2228. PubMed ID: 9723450 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]